|Bank/Broker||Analyst||Rating||Price target (EUR)
|goetzpartners securities Limited||Martin Brunninger||Outperform||6.82||16 November 2017|
|First Berlin Equity Research GmbH||Simon Scholes||Buy||7.10||16 April 2018|
|equinet Bank AG||Marietta Miemietz||Buy||3.70||19 Juni 2018|
Epigenomics AG is followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding Epigenomics’ performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Epigenomics or its management. Epigenomics does not, by its reference below or distribution, imply its endorsement of or concurrence with such information, conclusions or recommendations.